Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2037

Annual patent cliff calendar for 2037 — US pharmaceutical patents by expiration date.

Patents
1,615

Quick answer

1,615 indexed pharmaceutical patents have expiration dates in 2037. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 9730930

    Treatment for vitiligo

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9730965

    Perivascular stem cell composition for bone

    The Regents of the University of California · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9730966

    Method of reducing appetite in a human subject comprising administering krill oil composition

    AKER BIOMARINE ANTARCTIC AS · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9730978

    Compositions for treating dry eye disease

    Thc Regents of the University of California · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9730972

    Skin tightening lotion

    Ashley Diana Black International Holdings, LLC · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9730897

    Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9732067

    Compounds and methods for activating the apoptotic arm of the unfolded protein response

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9732073

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9731023

    Somatostatin receptor-based cancer therapy

    The Board of Regents of the University of Texas System · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9730941

    Methods and compositions for the inhibition of Pin1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9730892

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9731011

    Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

    EnGeneIC Molecular Delivery Pty Ltd · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9730989

    Compositions and methods for combination therapy with dengue virus and dendritic cells

    PrimeVax Immuno-Oncology · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9731002

    HIV-1 GP 120 V1/V2 antigens and immunological uses thereof

    The Regents of the University of California · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9732189

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9732070

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9732095

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Aurigene Discovery Technologies Limited · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9731037

    Scanning suspension comprising a particle with a diameter of at least 1 micrometer

    Universitair Medisch Centrum Utrecht · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9730993

    Engineered anthrax lethal toxin for targeted delivery

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9732080

    Azaindole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9730962

    Modalities for the treatment of degenerative diseases of the retina

    Astellas Institute for Regenerative Medicine · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9730954

    miRNAs as novel therapeutic adjuvants and biomarkers for the prognosis and treatment of drug resistant breast cancers

    The Board of Regents of the University of Texas System · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9732386

    Cell aging as a unique biomarker of major depression

    The Regents of the University of California · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9732337

    RNA nanoparticles and nanotubes

    The United Stated of America, as Represented by The Secretary, Department of Health and Human Services · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9732333

    Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells

    Protalix Ltd. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9732311

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Deuteria Beverages, LLC · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9732161

    Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9732062

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9731008

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9732114

    Compounds having anti-adhesive effects on cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9732110

    Nucleoside and nucleotide derivatives

    Enanta Pharmaceuticals, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9731009

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 2017231981

    COMPOSITIONS OF MULTIPLE ARIPIPRAZOLE PRODRUGS

    ALKERMES PHARMA IRELAND LTD [IE] · Granted Thu Aug 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Aug 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9737546

    Small molecules to enhance P53 activity

    The Regents of the University of California · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9738625

    Therapeutically active compounds and their methods of use

    Agios Pharmaceuticals, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9738726

    HER2-specific monoclonal antibodies and conjugates thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9738721

    Oncostatin M receptor antigen binding proteins

    Kiniksa Pharmaceuticals, GmbH · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9738720

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9738641

    Bicyclic inhibitors

    KalVista Pharmaceuticals Limited · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9738629

    Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9737623

    Antibodies that bind activatable antibodies and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9737598

    CD200 inhibitors and methods of use thereof

    Regents of the University of Minnesota · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9737530

    Process of making stable abuse-deterrent oral formulations

    Collegium Pharmaceutical, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9737513

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy

    PTC THERAPEUTICS, INC. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9737478

    Treatment of malaria

    National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS), The United States of America NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9737477

    Anti-aging dietary composition containing polysaccharides derived from ginseng and tuber fleeceflower root

    INFINITUS (CHINA) COMPANY LTD. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9738724

    Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use

    Sutro Biopharma, Inc. · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9738678

    Substituted nucleoside derivatives with antiviral and antimicrobial properties

    Board of Governors for Higher Education, State of Rhode Island and Providence Plantations · Granted Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2037?

1,615 published patents in our USPTO index have expiration dates falling in calendar year 2037.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.